Sort   by:  
 Page size 
UnknownHumoral and T-cell immune response after three doses of mRNA SARS-CoV-2 vaccines in fragile patients: the Italian VAX4FRAIL study.
Not available
S-EPMC9213871 | biostudies-literature
UnknownCOVID-19 Vaccination in Fragile Patients: Current Evidence and an Harmonized Transdisease Trial.
Not available
S-EPMC8383886 | biostudies-literature
UnknownNeutralizing antibodies to Omicron after the fourth SARS-CoV-2 mRNA vaccine dose in immunocompromised patients highlight the need of additional boosters.
Not available
S-EPMC9911671 | biostudies-literature
UnknownBNT162b2 vaccine induces antibody release in saliva: a possible role for mucosal viral protection?
Not available
S-EPMC9081904 | biostudies-literature
UnknownA 'Multiomic' Approach of Saliva Metabolomics, Microbiota, and Serum Biomarkers to Assess the Need of Hospitalization in Coronavirus Disease 2019.
Not available
S-EPMC8818445 | biostudies-literature
UnknownTocilizumab for patients with COVID-19 pneumonia. The single-arm TOCIVID-19 prospective trial.
Not available
S-EPMC7576974 | biostudies-literature
Sort   by:  
 Page size